ImmunoPrecise Antibodies Ltd (NAS:IPA) Stock News, Headlines & Updates
ImmunoPrecise Antibodies Ltd Stock News from GuruFocus
- 1
Jul 17, 2024
ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures
Business Wire ā¢ 8:00pm
Jul 15, 2024
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024
Business Wire ā¢ 8:00am
Jun 27, 2024
ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer
Business Wire ā¢ 8:00am
Jun 25, 2024
IPA's Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSaiā¢
Business Wire ā¢ 7:00am
Jun 12, 2024
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSaiā¢ Technology
Business Wire ā¢ 7:00am
Jun 10, 2024
BioStrand, ImmunoPrecise Antibodies' Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery
Business Wire ā¢ 7:00am
Jun 04, 2024
IPA's Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR)
Business Wire ā¢ 7:00am
Apr 22, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news